New Insight into the Role of Lipid Metabolism-related Proteins in Rheumatic Heart Valve Disease

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2022 Oct 29

PMID 36307855

Authors

Ting Xie

Xuan Chen

Cong Liu

Xingjiu Cai

Mei Xiang

Shiwu Liu

Ruzheng Li

Zhichuan Lin

Debing Liu

Ming Dong

Xinzhong Chen

Minghui Zou

Ping Qiao

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study was to determine the expression of lipid metabolism-related proteins in rheumatic heart valve disease (RHVD).

Methods: This retrospective study involved a total of 20 cases of moderate or severe rheumatic mitral valve stenosis and 4 cases of mitral regurgitation due to secondary causes from September 2018 to September 2021. The patients enrolled included 12 males and 12 females who underwent surgical excision of the mitral valve at the cardiac surgery department of Hainan General Hospital. The samples of mitral valve were collected during surgery treatment as the study group, and mitral valves collected from patients with ischemic heart disease were allocated into the control group. Hematoxylin-eosin (HE), oil red staining and immunohistochemical (IHC) staining were conducted to compare the expression of lipid metabolism-related proteins (ATP-binding cassette transporter A1 and acyl-coenzyme A: cholesterol acyltransferase-1), and real-time polymerase chain reaction (RT-PCR) was applied to compare the mRNA levels of ABCA1, ACAT1, and the inflammatory cytokines TNF-α, IL-10, and MCP-1.

Results: In general, the rheumatic mitral valve showed leaflet thickening along with border adhesions and visible yellow fats. Oil red O staining also revealed the abovementioned results as well as fat cells. Both ABCA1 and ACAT1 were expressed in the rheumatic mitral valve via IHC, whereas only ACAT1 showed a faint level of expression in the ischemic mitral valve with no expression of ABCA1. In addition, compared with the ischemic mitral valve, RT-PCT showed increased mRNA expression levels of ABCA1, ACAT1, and the inflammatory cytokines TNF-α, IL-10, and MCP-1 (P < 0.05). After dividing the RMs into two groups for RT-PCR, we found that the higher the expression of ABCA1 and ACAT1 was, the lower the relative expression of inflammatory factors.

Conclusion: This study showed that adipose tissue, adipose cells, and lipid transport-related proteins were expressed strongly in the rheumatic mitral valve, suggesting that adipose tissue formation might be one of the important pathways in the pathology of rheumatic heart disease. In addition, adipose tissue and adipocytes were also involved in the inflammatory process. These data provide new insight into pathological mechanisms in rheumatic heart disease.

Citing Articles

Causal effects of inflammatory cytokines on cardiovascular diseases: Insights from genetic evidence.

Chen Y, Zhong A Heliyon. 2024; 10(15):e35447.

PMID: 39165962 PMC: 11334864. DOI: 10.1016/j.heliyon.2024.e35447.

References

Peters F, Karthikeyan G, Abrams J, Muhwava L, Zuhlke L . Rheumatic heart disease: current status of diagnosis and therapy. Cardiovasc Diagn Ther. 2020; 10(2):305-315. PMC: 7225445. DOI: 10.21037/cdt.2019.10.07. View

Antonini-Canterin F, Leiballi E, Enache R, Popescu B, Rosca M, Cervesato E . Hydroxymethylglutaryl coenzyme-a reductase inhibitors delay the progression of rheumatic aortic valve stenosis a long-term echocardiographic study. J Am Coll Cardiol. 2009; 53(20):1874-9. DOI: 10.1016/j.jacc.2009.01.064. View

Gomez R, Conde J, Scotece M, Gomez-Reino J, Lago F, Gualillo O . What's new in our understanding of the role of adipokines in rheumatic diseases?. Nat Rev Rheumatol. 2011; 7(9):528-36. DOI: 10.1038/nrrheum.2011.107. View

Sliwa K, White A, Milan P, Mocumbi A, Zilla P, Wood D . Momentum builds for a global response to rheumatic heart disease. Eur Heart J. 2018; 39(48):4229-4232. DOI: 10.1093/eurheartj/ehy763. View

Tandon R, Sharma M, Chandrashekhar Y, Kotb M, Yacoub M, Narula J . Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol. 2013; 10(3):171-7. DOI: 10.1038/nrcardio.2012.197. View

Sliwa K, Zilla P . Rheumatic heart disease: the tip of the iceberg. Circulation. 2012; 125(25):3060-2. DOI: 10.1161/CIRCULATIONAHA.112.114199. View

Chopra P, Gulwani H . Pathology and pathogenesis of rheumatic heart disease. Indian J Pathol Microbiol. 2008; 50(4):685-97. View

Fantuzzi G . Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005; 115(5):911-9. DOI: 10.1016/j.jaci.2005.02.023. View

Ogle M, Segar C, Sridhar S, Botchwey E . Monocytes and macrophages in tissue repair: Implications for immunoregenerative biomaterial design. Exp Biol Med (Maywood). 2016; 241(10):1084-97. PMC: 4898192. DOI: 10.1177/1535370216650293. View

10.

Sanchez-Gurmaches J, Guertin D . Adipocyte lineages: tracing back the origins of fat. Biochim Biophys Acta. 2013; 1842(3):340-51. PMC: 3805734. DOI: 10.1016/j.bbadis.2013.05.027. View

11.

Liang Y, Yang X, Ma L, Cai X, Wang L, Yang C . Homocysteine-mediated cholesterol efflux via ABCA1 and ACAT1 DNA methylation in THP-1 monocyte-derived foam cells. Acta Biochim Biophys Sin (Shanghai). 2013; 45(3):220-8. DOI: 10.1093/abbs/gms119. View

12.

Edwards W, Peterson K, Edwards J . Active valvulitis associated with chronic rheumatic valvular disease and active myocarditis. Circulation. 1978; 57(1):181-5. DOI: 10.1161/01.cir.57.1.181. View

13.

Rajamannan N, Antonini-Canterin F, Moura L, Zamorano J, Rosenhek R, Best P . Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive?. Indian Heart J. 2009; 61(1):14-23. PMC: 3951844. View

14.

Watkins D, Johnson C, Colquhoun S, Karthikeyan G, Beaton A, Bukhman G . Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. N Engl J Med. 2017; 377(8):713-722. DOI: 10.1056/NEJMoa1603693. View

15.

Torres S, Fabersani E, Marquez A, Gauffin-Cano P . Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics. Eur J Nutr. 2018; 58(1):27-43. DOI: 10.1007/s00394-018-1790-2. View

16.

Kloting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schon M . Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun. 2005; 339(1):430-6. DOI: 10.1016/j.bbrc.2005.11.039. View

17.

Robinson G, Pineda-Torra I, Ciurtin C, Jury E . Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies. J Clin Invest. 2022; 132(2). PMC: 8759788. DOI: 10.1172/JCI148552. View

18.

Ouimet M, Marcel Y . Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol. 2011; 32(3):575-81. DOI: 10.1161/ATVBAHA.111.240705. View

19.

Cuchel M, Rader D . Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?. Circulation. 2006; 113(21):2548-55. DOI: 10.1161/CIRCULATIONAHA.104.475715. View

20.

Berry R, Rodeheffer M . Characterization of the adipocyte cellular lineage in vivo. Nat Cell Biol. 2013; 15(3):302-8. PMC: 3721064. DOI: 10.1038/ncb2696. View